{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:53:31Z","timestamp":1790726011987,"version":"4.1.0"},"reference-count":58,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,7,25]],"date-time":"2014-07-25T00:00:00Z","timestamp":1406246400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2014,7,25]],"date-time":"2014-07-25T00:00:00Z","timestamp":1406246400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>High serum free fatty acid (FFA) levels are associated with metabolic syndrome (MS). This study aimed to assess the association of fasting serum FFAs with nonalcoholic fatty liver disease (NAFLD) in a Chinese population. A total of 840 subjects fulfilled the diagnostic criteria of NAFLD and 331 healthy control participants were enrolled in this cross-sectional study. Fasting serum FFA levels and other clinical and laboratory parameters were measured. NAFLD patients had significantly higher serum FFA levels than controls (<jats:italic>P<\/jats:italic> &lt; 0.001). Serum FFA levels were significantly and positively correlated with parameters of MS, inflammation indexes and markers of hepatocellular damage. Elevated serum FFA levels were found in NAFLD subjects with individual components of MS (obesity, hypertriglyceridaemia and hyperglycaemia). Stepwise regression showed that serum FFA levels were an independent factor predicting advanced fibrosis (FIB-4 \u2265 1.3) in NAFLD patients. Serum FFA levels correlated with NAFLD and could be used as an indicator for predicting advanced fibrosis in NAFLD patients.<\/jats:p>","DOI":"10.1038\/srep05832","type":"journal-article","created":{"date-parts":[[2014,7,25]],"date-time":"2014-07-25T09:03:38Z","timestamp":1406279018000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":151,"title":["Association between serum free fatty acid levels and nonalcoholic fatty liver disease: a cross-sectional study"],"prefix":"10.1038","volume":"4","author":[{"given":"Juanwen","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chengfu","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yani","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanle","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,7,25]]},"reference":[{"key":"BFsrep05832_CR1","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1517\/14728222.2013.811024","volume":"17","author":"VG Athyros","year":"2013","unstructured":"Athyros, V. G., Katsiki, N. & Karagiannis, A. Comment on: Novel therapeutic targets for non-alcoholic fatty liver disease. Expert Opin Ther Targets. 17, 861\u2013862 (2013).","journal-title":"Expert Opin Ther Targets."},{"key":"BFsrep05832_CR2","doi-asserted-by":"crossref","first-page":"5169","DOI":"10.2174\/13816128113199990336","volume":"19","author":"N Bhala","year":"2013","unstructured":"Bhala, N., Jouness, R. I. & Bugianesi, E. Epidemiology and natural history of patients with NAFLD. Curr Pharm Des. 19, 5169\u20135176 (2013).","journal-title":"Curr Pharm Des."},{"key":"BFsrep05832_CR3","doi-asserted-by":"crossref","first-page":"5177","DOI":"10.2174\/1381612811319290003","volume":"19","author":"A Lonardo","year":"2013","unstructured":"Lonardo, A., Sookoian, S., Chonchol, M., Loria, P. & Targher, G. Cardiovascular and systemic risk in nonalcoholic fatty liver disease - atherosclerosis as a major player in the natural course of NAFLD. Curr Pharm Des. 19, 5177\u20135192 (2013).","journal-title":"Curr Pharm Des."},{"key":"BFsrep05832_CR4","doi-asserted-by":"crossref","first-page":"5334","DOI":"10.3748\/wjg.v19.i32.5334","volume":"19","author":"X Liao","year":"2013","unstructured":"Liao, X., Cao, X., Liu, J. & Xie, X. Prevalence and features of fatty liver detected by physical examination in Guangzhou. World J Gastroenterol. 19, 5334\u20135339 (2013).","journal-title":"World J Gastroenterol."},{"key":"BFsrep05832_CR5","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/jgh.12428","volume":"29","author":"Z Li","year":"2014","unstructured":"Li, Z. et al. Prevalence of nonalcoholic fatty liver disease in mainland of China: a meta-analysis of published studies. J Gastroenterol Hepatol. 29, 42\u201351 (2014).","journal-title":"J Gastroenterol Hepatol."},{"key":"BFsrep05832_CR6","doi-asserted-by":"crossref","first-page":"e87523","DOI":"10.1371\/journal.pone.0087523","volume":"9","author":"S Petta","year":"2014","unstructured":"Petta, S. et al. Glucokinase regulatory protein gene polymorphism affects liver fibrosis in non-alcoholic Fatty liver disease. PLoS One. 9, e87523 (2014).","journal-title":"PLoS One."},{"key":"BFsrep05832_CR7","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1007\/s12263-013-0383-1","volume":"9","author":"L Miele","year":"2014","unstructured":"Miele, L. et al. A case-control study on the effect of metabolic gene polymorphisms, nutrition and their interaction on the risk of non-alcoholic fatty liver disease. Genes. Nutr. 9, 383 (2014).","journal-title":"Genes. Nutr."},{"key":"BFsrep05832_CR8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plipres.2008.08.001","volume":"48","author":"G Musso","year":"2009","unstructured":"Musso, G., Gambino, R. & Cassader, M. Recent insights into hepatic lipid metabolismin non-alcoholic fatty liver disease (NAFLD). Prog Lipid Res. 48, 1\u201326 (2009).","journal-title":"Prog Lipid Res."},{"key":"BFsrep05832_CR9","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.arcmed.2013.12.010","volume":"45","author":"MN Stankovi\u0107","year":"2014","unstructured":"Stankovi\u0107, M. N. et al. Time-dependent Changes and Association Between Liver Free Fatty Acids, Serum Lipid Profile and Histological Features in Mice Model of Nonalcoholic Fatty Liver Disease. Arch Med Res. 45, 116\u2013124 (2014).","journal-title":"Arch Med Res."},{"key":"BFsrep05832_CR10","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","volume":"115","author":"KL Donnelly","year":"2005","unstructured":"Donnelly, K. L. et al. Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease. J Clin Invest. 115, 1343\u20131351 (2005).","journal-title":"J Clin Invest."},{"key":"BFsrep05832_CR11","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1186\/1471-2458-14-481","volume":"14","author":"S Hong","year":"2014","unstructured":"Hong, S. et al. Association between cardiorespiratory fitness and the prevalence of metabolic syndrome among Korean adults: a cross sectional study. BMC Public Health. 14, 481 (2014).","journal-title":"BMC Public Health."},{"key":"BFsrep05832_CR12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0140-6736(09)61794-3","volume":"375","author":"RH Eckel","year":"2010","unstructured":"Eckel, R. H., Alberti, K. G., Grundy, S. M. & Zimmet, P. Z. The metabolic syndrome. Lancet. 375, 181\u2013183 (2010).","journal-title":"Lancet."},{"key":"BFsrep05832_CR13","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.ypmed.2013.09.023","volume":"57","author":"B Xi","year":"2013","unstructured":"Xi, B., He, D., Hu, Y. & Zhou, D. Prevalence of metabolic syndrome and its influencing factors among the Chinese adults: the China Health and Nutrition Survey in 2009. Prev Med. 57, 867\u2013871 (2013).","journal-title":"Prev Med."},{"key":"BFsrep05832_CR14","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1038\/srep01491","volume":"3","author":"E Chiefari","year":"2013","unstructured":"Chiefari, E. et al. A polymorphism of HMGA1 is associated with increased risk of metabolic syndrome and related components. Sci Rep. 3, 1491 (2013).","journal-title":"Sci Rep."},{"key":"BFsrep05832_CR15","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1097\/MOL.0b013e32832b2024","volume":"20","author":"JT Haas","year":"2009","unstructured":"Haas, J. T. & Biddinger, S. B. Dissecting the role of insulin resistance in the metabolic syndrome. Curr Opin Lipidol. 20, 206\u2013210 (2009).","journal-title":"Curr Opin Lipidol."},{"key":"BFsrep05832_CR16","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-230X-12-20","volume":"12","author":"NC Chavez-Tapia","year":"2012","unstructured":"Chavez-Tapia, N. C., Rosso, N. & Tiribelli, C. Effect of intracellular lipid accumulation in a new model of non-alcoholic fatty liver disease. BMC Gastroenterol. 12, 20 (2012).","journal-title":"BMC Gastroenterol."},{"key":"BFsrep05832_CR17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/1756283X11430859","volume":"5","author":"JM Kneeman","year":"2012","unstructured":"Kneeman, J. M., Misdraji, J. & Corey, K. E. Secondary causes of nonalcoholic fatty liver disease. Therap Adv Gastroenterol. 5, 199\u2013207 (2012).","journal-title":"Therap Adv Gastroenterol."},{"key":"BFsrep05832_CR18","first-page":"1","volume":"28","author":"G Fr\u00fchbeck","year":"2014","unstructured":"Fr\u00fchbeck, G., M\u00e9ndez-Gim\u00e9nez, L., Fern\u00e1ndez-Formoso, J. A., Fern\u00e1ndez, S. & Rodr\u00edguez, A. Regulation of adipocyte lipolysis. Nutr Res Rev. 28, 1\u201331 (2014).","journal-title":"Nutr Res Rev."},{"key":"BFsrep05832_CR19","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1093\/jb\/mvn105","volume":"144","author":"MW Ruddock","year":"2008","unstructured":"Ruddock, M. W. et al. Saturated fatty acids inhibit hepatic insulin action by modulating insulin receptor expression and post-receptor signalling. J Biochem. 144, 599\u2013607 (2008).","journal-title":"J Biochem."},{"key":"BFsrep05832_CR20","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1038\/ajg.2010.152","volume":"105","author":"HM Patton","year":"2010","unstructured":"Patton, H. M. et al. Association between metabolic syndrome and liver histology among children with nonalcoholic Fatty liver disease. Am J Gastroenterol. 105, 2093\u20132102 (2010).","journal-title":"Am J Gastroenterol."},{"key":"BFsrep05832_CR21","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/j.jhep.2007.12.011","volume":"48","author":"CZ Larter","year":"2008","unstructured":"Larter, C. Z. et al. Hepatic free fatty acids accumulate in experimental steatohepatitis: role of adaptive pathways. J Hepatol. 48, 638\u2013647 (2008).","journal-title":"J Hepatol."},{"key":"BFsrep05832_CR22","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1002\/hep.26225","volume":"57","author":"LP Bechmann","year":"2013","unstructured":"Bechmann, L. P. et al. Free fatty acids repress small heterodimer partner (SHP) activation and adiponectin counteracts bile acid-inducedliver injury in superobese patients with nonalcoholic steatohepatitis. Hepatology. 57, 1394\u20131406 (2013).","journal-title":"Hepatology."},{"key":"BFsrep05832_CR23","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1111\/j.1440-1746.2008.05733.x","volume":"24","author":"M Ricchi","year":"2009","unstructured":"Ricchi, M. et al. Differential effect of oleic and palmitic acid on lipid accumulation and apoptosis in cultured hepatocytes. J Gastroenterol Hepatol. 24, 830\u2013840 (2009).","journal-title":"J Gastroenterol Hepatol."},{"key":"BFsrep05832_CR24","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/BF03347199","volume":"28","author":"G Marchesini","year":"2005","unstructured":"Marchesini, G. et al. Aminotransferase and gamma-glutamyltranspeptidase levels in obesity are associated with insulin resistance and the metabolic syndrome. J Endocrinol Invest. 28, 333\u2013339 (2005).","journal-title":"J Endocrinol Invest."},{"key":"BFsrep05832_CR25","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1373\/clinchem.2006.081257","volume":"53","author":"Y Chang","year":"2007","unstructured":"Chang, Y., Ryu, S., Sung, E. & Jang, Y. Higher concentrations of alanineamino transferase within the reference interval predict nonalcoholic fatty liver disease. Clin Chem. 53, 686\u2013692 (2007).","journal-title":"Clin Chem."},{"key":"BFsrep05832_CR26","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.1440-1746.2004.03362.x","volume":"19","author":"SH Park","year":"2004","unstructured":"Park, S. H. et al. Insulin resistance and C-reactive protein as independent risk factors for non-alcoholic fatty liver disease in non-obese Asian men. J Gastroenterol Hepatol. 19, 694\u2013698 (2004).","journal-title":"J Gastroenterol Hepatol."},{"key":"BFsrep05832_CR27","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1111\/j.1440-1746.2007.04952.x","volume":"22","author":"JG Fan","year":"2007","unstructured":"Fan, J. G. et al. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific? J Gastroenterol Hepatol. 22, 794\u2013800 (2007).","journal-title":"J Gastroenterol Hepatol."},{"key":"BFsrep05832_CR28","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1111\/j.1440-1746.2011.06774.x","volume":"26","author":"LA Adams","year":"2011","unstructured":"Adams, L. A. et al. Complex non-invasive fibrosis models are more accurate than simple models in non-alcoholic fatty liver disease. J Gastroenterol Hepatol. 26, 1536\u20131543 (2011).","journal-title":"J Gastroenterol Hepatol."},{"key":"BFsrep05832_CR29","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1751-2980.2008.00331.x","volume":"9","author":"MD Zeng","year":"2008","unstructured":"Zeng, M. D. et al. Chinese National Consensus Workshop on Nonalcoholic Fatty Liver Disease. J Dig Dis. 9, 108\u2013112 (2008).","journal-title":"J Dig Dis."},{"key":"BFsrep05832_CR30","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/j.1751-2980.2011.00487.x","volume":"12","author":"SH Chen","year":"2011","unstructured":"Chen, S. H., He, F., Zhou, H. L., Wu, H. R., Xia, C. & Li, Y. M. Relationship between nonalcoholic fatty liver disease and metabolic syndrome. J Dig Dis. 12, 125\u2013130 (2011).","journal-title":"J Dig Dis."},{"key":"BFsrep05832_CR31","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1159\/000362568","volume":"64","author":"D Giannini","year":"2014","unstructured":"Giannini, D., Kuschnir, M. C. & Szklo, M. Metabolic Syndrome in Overweight and Obese Adolescents: A Comparison of Two Different Diagnostic Criteria. Ann Nutr Metab. 64, 71\u201379 (2014).","journal-title":"Ann Nutr Metab."},{"key":"BFsrep05832_CR32","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.beem.2005.07.003","volume":"19","author":"P Kovacs","year":"2005","unstructured":"Kovacs, P. & Stumvoll, M. Fatty acids and insulin resistance in muscle and liver. Best Pract Res Clin Endocrinol Metab. 19, 625\u2013635 (2005).","journal-title":"Best Pract Res Clin Endocrinol Metab."},{"key":"BFsrep05832_CR33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.vph.2012.05.003","volume":"57","author":"C Capurso","year":"2012","unstructured":"Capurso, C. & Capurso, A. From excess adiposity to insulin resistance: the role of free fatty acids. Vascul Pharmacol. 57, 91\u201397 (2012).","journal-title":"Vascul Pharmacol."},{"key":"BFsrep05832_CR34","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","volume":"34","author":"G Vernon","year":"2011","unstructured":"Vernon, G., Baranova, A. & Younossi, Z. M. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 34, 274\u2013285 (2011).","journal-title":"Aliment Pharmacol Ther."},{"key":"BFsrep05832_CR35","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/1471-2350-14-54","volume":"14","author":"PJ Hsiao","year":"2013","unstructured":"Hsiao, P. J. et al. Risk interaction of obesity, insulin resistance and hormone-sensitive lipase promoter polymorphisms (LIPE-60 C &gt; G) in the development of fatty liver. BMC Med Genet. 14, 54 (2013).","journal-title":"BMC Med Genet."},{"key":"BFsrep05832_CR36","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1432-1033.1989.tb14842.x","volume":"182","author":"P Stralfors","year":"1989","unstructured":"Stralfors, P. & Honnor, R. C. Insulin-induced dephosphorylation of hormone-sensitive lipase. Correlation with lipolysis and cAMP-dependent protein kinase activity. Eur J Biochem. 182, 379\u2013385 (1989).","journal-title":"Eur J Biochem."},{"key":"BFsrep05832_CR37","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/01.mol.0000226118.43178.98","volume":"17","author":"IC Gaemers","year":"2006","unstructured":"Gaemers, I. C. & Groen, A. K. New insights in the pathogenesis of non-alcoholic fatty liver disease. Curr Opin Lipidol. 17, 268\u2013273 (2006).","journal-title":"Curr Opin Lipidol."},{"key":"BFsrep05832_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.plipres.2008.08.001","volume":"48","author":"G Musso","year":"2009","unstructured":"Musso, G., Gambino, R. & Cassader, M. Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD). Prog Lipid Res. 48, 1\u201326 (2009).","journal-title":"Prog Lipid Res."},{"key":"BFsrep05832_CR39","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/MOL.0000000000000080","volume":"25","author":"MM Jacome-Sosa","year":"2014","unstructured":"Jacome-Sosa, M. M. & Parks, E. J. Fatty acid sources and their fluxes as they contribute to plasma triglyceride concentrations and fatty liver in humans. Curr Opin Lipidol. 25, 213\u2013220 (2014).","journal-title":"Curr Opin Lipidol."},{"key":"BFsrep05832_CR40","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.clinbiochem.2010.04.003","volume":"43","author":"S Narasimhan","year":"2010","unstructured":"Narasimhan, S. et al. Oxidative stress is independently associated with non-alcoholic fatty liver disease (NAFLD) in subjects with and without type 2 diabetes. Clin Biochem. 43, 815\u2013821 (2010).","journal-title":"Clin Biochem."},{"key":"BFsrep05832_CR41","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00394-013-0516-8","volume":"53","author":"J Xiao","year":"2014","unstructured":"Xiao, J. et al. Epigallocatechin gallate attenuates fibrosis, oxidative stress and inflammation in non-alcoholic fatty liver disease rat model through TGF\/SMAD, PI3 K\/Akt\/FoxO1 and NF-kappa B pathways. Eur J Nutr. 53, 187\u2013199 (2014).","journal-title":"Eur J Nutr."},{"key":"BFsrep05832_CR42","doi-asserted-by":"crossref","first-page":"77","DOI":"10.2337\/diacare.27.1.77","volume":"27","author":"JS Pankow","year":"2004","unstructured":"Pankow, J. S. et al. Fasting plasma free fatty acids and risk of type2 diabetes: the atherosclerosis risk in communities study. Diabetes Care. 27, 77\u201382 (2004).","journal-title":"Diabetes Care."},{"key":"BFsrep05832_CR43","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1111\/apt.12078","volume":"36","author":"A Ahmed","year":"2012","unstructured":"Ahmed, A. & Forrest, E. H. Commentary: Physical activity and NAFLD--cause or effect? Aliment Pharmacol Ther. 36, 1097\u20131098 (2012).","journal-title":"Aliment Pharmacol Ther."},{"key":"BFsrep05832_CR44","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2337\/diabetes.49.5.701","volume":"49","author":"M Roden","year":"2000","unstructured":"Roden, M. et al. Effects of free fatty acid elevation on postabsorptive endogenous glucose production and gluconeogenesis in humans. Diabetes. 49, 701\u2013717 (2000).","journal-title":"Diabetes."},{"key":"BFsrep05832_CR45","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1053\/jhep.2003.50229","volume":"37","author":"P Mofrad","year":"2003","unstructured":"Mofrad, P. et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. Hepatology. 37, 1286\u20131292 (2003).","journal-title":"Hepatology."},{"key":"BFsrep05832_CR46","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1002\/hep.22429","volume":"48","author":"AL Fracanzani","year":"2008","unstructured":"Fracanzani, A. L. et al. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. Hepatology. 48, 792\u2013808 (2008).","journal-title":"Hepatology."},{"key":"BFsrep05832_CR47","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.atherosclerosis.2012.07.018","volume":"224","author":"RD Santos","year":"2012","unstructured":"Santos, R. D. & Agewall, S. Non-alcoholic fatty liver disease and cardiovascular disease. Atherosclerosis. 224, 324\u2013325 (2012).","journal-title":"Atherosclerosis."},{"key":"BFsrep05832_CR48","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.2337\/diabetes.52.12.2882","volume":"52","author":"D Tripathy","year":"2003","unstructured":"Tripathy, D. et al. Elevation of free fatty acids induces inflammation and impairs vascular reactivity in healthy subjects. Diabetes. 52, 2882\u20132887 (2003).","journal-title":"Diabetes."},{"key":"BFsrep05832_CR49","doi-asserted-by":"crossref","first-page":"432575","DOI":"10.1155\/2012\/432575","volume":"2012","author":"K Naruse","year":"2012","unstructured":"Naruse, K. et al. Chemokine and free fatty acid levels in insulin-resistant state of successful pregnancy: a preliminary observation. Mediators Inflamm. 2012, 432575 (2012).","journal-title":"Mediators Inflamm."},{"key":"BFsrep05832_CR50","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s12031-013-0068-7","volume":"51","author":"LM Tracy","year":"2013","unstructured":"Tracy, L. M. et al. Exposure to the saturated free fatty acid palmitate alters BV-2 microglia inflammatory response. J Mol Neurosci. 51, 805\u2013812 (2013).","journal-title":"J Mol Neurosci."},{"key":"BFsrep05832_CR51","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","volume":"34","author":"G Vernon","year":"2011","unstructured":"Vernon, G., Baranova, A. & Younossi, Z. M. Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther. 34, 274\u2013285 (2011).","journal-title":"Aliment Pharmacol Ther."},{"key":"BFsrep05832_CR52","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1111\/apt.12046","volume":"36","author":"Y Yilmaz","year":"2012","unstructured":"Yilmaz, Y. Review article: is non-alcoholic fatty liver disease a spectrum, or are steatosis and non-alcoholic steatohepatitis distinct conditions? Aliment Pharmacol Ther. 36, 815\u2013823 (2012).","journal-title":"Aliment Pharmacol Ther."},{"key":"BFsrep05832_CR53","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s11901-014-0227-5","volume":"13","author":"CM Fielding","year":"2014","unstructured":"Fielding, C. M. & Angulo, P. Hepatic Steatosis and Steatohepatitis: Are they Really Two Distinct Entities? Curr Hepatology Rep. 13, 151\u2013158 (2014).","journal-title":"Curr Hepatology Rep."},{"key":"BFsrep05832_CR54","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1111\/j.1478-3231.2012.02804.x","volume":"32","author":"S Ballestri","year":"2012","unstructured":"Ballestri, S. et al. Ultrasonographic fatty liver indicator, a novel score which rules out NASH and is correlated with metabolic parameters in NAFLD. Liver Int. 32, 1242\u20131252 (2012).","journal-title":"Liver Int."},{"key":"BFsrep05832_CR55","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1002\/hep.24452","volume":"54","author":"R Hernaez","year":"2011","unstructured":"Hernaez, R. et al. Diagnostic accuracy and reliability of ultrasonography for the detection of fatty liver: a meta-analysis. Hepatology. 54, 1082\u20131090 (2011).","journal-title":"Hepatology."},{"key":"BFsrep05832_CR56","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/j.1751-2980.2012.00631.x","volume":"13","author":"YH Xun","year":"2012","unstructured":"Xun, Y. H. et al. Suboptimal performance of simple noninvasive tests for advanced fibrosis in Chinese patients with nonalcoholic fatty liver disease. J Dig Dis. 13, 588\u2013595 (2012).","journal-title":"J Dig Dis."},{"key":"BFsrep05832_CR57","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1136\/gut.2010.216077","volume":"59","author":"S McPherson","year":"2010","unstructured":"McPherson, S., Stewart, S. F., Henderson, E., Burt, A. D. & Day, C. P. Simple non-invasive fibrosis scoring systems can reliably exclude advanced fibrosis in patients with non-alcoholic fatty liver disease. Gut. 59, 1265\u20131269 (2010).","journal-title":"Gut."},{"key":"BFsrep05832_CR58","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-230X-12-2","volume":"12","author":"Y Sumida","year":"2012","unstructured":"Sumida, Y., Yoneda, M. & Hyogo, H. Validation of the FIB4 index in a Japanese nonalcoholic fatty liver disease population. BMC Gastroenterol. 12, 2 (2012).","journal-title":"BMC Gastroenterol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/srep05832","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep05832.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/srep05832.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,6]],"date-time":"2023-01-06T08:13:11Z","timestamp":1672992791000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/srep05832"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,25]]},"references-count":58,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,12,17]]}},"alternative-id":["BFsrep05832"],"URL":"https:\/\/doi.org\/10.1038\/srep05832","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,25]]},"assertion":[{"value":"3 April 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5832"}}